Human CYP2D6 and metabolism of m-chlorophenylpiperazine-Reference-Cited by-同舟云学术

Human CYP2D6 and metabolism of m-chlorophenylpiperazine

Published:1998-12 Issue:11 Volume:44 Page:1185-1191
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Rotzinger Susan,Fang Jian,Coutts Ronald T,Baker Glen B

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference53 articles.

1. Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan;Barbhaiya;Br J Clin Pharmacol,1996

2. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions;Bertz;Clin Pharmacokinet,1997

3. In vitro approaches can predict human drug metabolism;Birkett;Trends Pharmacol Sci,1993

4. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes;Bourrie;J Pharmacol Exp Ther,1996

5. Clinical significance of the sparteine/debrisoquine oxidation polymorphism;Brosen;Eur J Clin Pharmacol,1989

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP2D6 polymorphism may contribute to Trazodone-induced hepatotoxicity: a rare case of drug-drug-gene induced liver injury;Acta Gastro Enterologica Belgica;2024-06

2. The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants;Current Drug Metabolism;2021-07

3. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12

4. Clinical Relevance of Pharmacogenetics in Serotonin Syndrome;Case Reports in Psychiatry;2020-10-08

5. Coma Reversal After Intravenous Lipid Emulsion Therapy in a Trazodone-Poisoned Patient;Clinical Neuropharmacology;2020-01